Hans-Peter Stoll

Showing 1-10 of 10 articles

Coronary interventions

Thin- versus thick-strut polymer-free biolimus-eluting stents: the BioFreedom QCA randomised trial

Sabaté M, Jensen LO, Tilsted H, Moreno R, García del Blanco B, Macaya C, Perez de Prado A, Cequier A, Pérez-Fuentes P, Schütte D, Costa R, Stoll H, Flensted Lassen J

June 25, 2021 | 10.4244/EIJ-D-20-01162

Coronary interventions

Drug-coated stents versus bare metal stents in Academic Research Consortium-defined high bleeding risk patients

Marquis-Gravel G, Urban P, Copt S, Capodanno D, Pocock S, Sadozai Slama S, Stoll H, Tanguay J, Mehran R, Leon M, Rao S, Morice M, Krucoff M

June 25, 2021 | 10.4244/EIJ-D-20-00749

Coronary interventions

Impact of ticagrelor monotherapy on two-year clinical outcomes in patients with long stenting: a post hoc analysis of the GLOBAL LEADERS trial

Takahashi K, Chichareon P, Modolo R, Kogame N, Chang C, Tomaniak M, Moschovitis A, Curzen N, Haude M, Jung W, Holmvang L, Garg S, Tijssen J, Wykrzykowska J, de Winter R, Hamm C, Steg P, Stoll H, Onuma Y, Valgimigli M, Vranckx P, Windecker S, Serruys P

October 23, 2020 | 10.4244/EIJ-D-19-00498

Coronary interventions

Establishment of healing profile and neointimal transformation in the new polymer-free biolimus A9-coated coronary stent by longitudinal sequential optical coherence tomography assessments: the EGO-BIOFREEDOM study

Lee WLS, Tam FCC, Chan KKW, Lam S, Kong S-L, Shea CP, Wong MKL, Wong AYT, Yung ASY, Zhang L-W, Lam Y-M, Mintz GS, Costa R, Stoll H, Maehara A

September 20, 2018 | 10.4244/EIJ-D-18-00061

Biolimus A9 polymer-free coated stents in high bleeding risk patients undergoing complex PCI: evidence from the LEADERS FREE randomised clinical trial

Lipiecki J, Brunel P, Morice M, Roguelov C, Walsh S, Richardt G, Eerdmans P, Zambahari R, Berland J, Copt S, Stoll H, Urban P

July 20, 2018 | 10.4244/EIJ-D-18-00293

Two-year outcomes of high bleeding risk patients with acute coronary syndrome after Biolimus A9 polymer-free drug-coated stents: a LEADERS FREE substudy

Jensen C, Naber C, Urban P, Ong PJ, Valdés Chávarri M, Abizaid A, Pocock S, Fabbiocchi F, Dubois C, Copt S, Stoll H, Morice M

March 20, 2018 | 10.4244/EIJ-D-17-00720

Outcomes in patients undergoing multivessel percutaneous coronary intervention using sirolimus-eluting stents: a report from the e-SELECT registry

Cuculi F, Banning A, Abizaid A, Bartorelli A, Baux A, Dzavik V, Ellis S, Gao R, Holmes D, Jeong M, Legrand V, Neumann F, Nyakern M, Spaulding C, Stoll H, Worthley S, Urban P

December 30, 2011 | 10.4244/EIJV7I8A152

Effect of gender differences on early and mid-term clinical outcome after percutaneous or surgical coronary revascularisation in patients with multivessel coronary artery disease: Insights from ARTS I and ARTS II

Vaina S, Voudris V, Morice M, De Bruyne B, Colombo A, Macaya C, Richardt G, Fajadet J, Hamm C, Schuijer M, Macours N, Stoll H, Cokkinos D, Stefanadis C, Serruys P

January 20, 2009

Three-year follow-up of the ARTS-II# – Sirolimus-eluting stents for the treatment of patients with multivessel coronary artery disease

Serruys P, Daemen J, Morice M, De Bruyne B, Colombo A, Macaya C, Richardt G, Fajadet J, Hamm C, Dawkins K, Vranckx P, Bressers M, van Domburg R, Schuijer M, Wittebols K, Pieters M, Stoll H

January 20, 2008

One-year results of coronary revascularization in diabetic patients with multivessel coronary artery disease.

Macaya C, Garcia-Garcia H, Colombo A, Morice M, Legrand V, Kuck K, Sheiban I, Suttorp MJ, Carrié D, Vrolix M, Wittebols K, Stoll H, Donohoe D, Bressers M, Serruys P

May 20, 2006

Latest news

NEW ISSUE

200 Issues at the Heart of Interventional Cardiology

January 28, 2022

AHEAD OF PRINT

Simulation-based planning of transcatheter left atrial appendage occlusion

FREE ARTICLE - Nils Perrin et al

January 26, 2022

AHEAD OF PRINT

Features of atherosclerosis in patients with angina and no obstructive coronary artery disease

FREE ARTICLE - Dario Pellegrini et al

January 27, 2022

AHEAD OF PRINT

Trends and predictors of radiation exposure in percutaneous coronary intervention: the PROTECTION VIII study

FREE ARTICLE - Thomas J. Stocker et al

January 24, 2022

GUIDELINES

2021 ESC/EACTS Guidelines for the management of valvular heart disease

FREE ARTICLE - Alec Vahanian et al.

December 22, 2021

AHEAD OF PRINT

Three-year TAVI outcomes for BAV vs TAV

FREE ARTICLE - Dao Zhou et al.

January 20, 2022

AHEAD OF PRINT

Percutaneous management of left ventricular assist device outflow graft obstruction

FREE ARTICLE - Aleksandra Gasecka et al.